BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Bausch Health Announces First Quarter 2024 Results Financial Results Adjusted EBITDA Pharmaceutical Industry Revenue Growth Bausch Health
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Bausch Health annonce ses résultats du premier trimestre 2024 Résultats Financiers EBITDA Ajusté Hausse Des Revenus Bausch Santé Industrie Pharmaceutique
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Electrovaya Schedules Q2-2024 Financial Results Release and Conference Call Lithium-ion Battery Conference Call Financial Announcement Electrovaya Q2-2024 Results
BRIEF published on 05/02/2024 at 13:05, 1 year 10 months ago Electrovaya prévoit la publication de ses résultats financiers du deuxième trimestre 2024 et une conférence téléphonique Conférence Téléphonique Electrovaya Annonce Financière Batterie Aux Ions Lithium Résultats Du T2-2024
BRIEF published on 05/02/2024 at 12:59, 1 year 10 months ago Apex Fundrock Limited Discloses Substantial Position in Tyman PLC Apex Fundrock Limited Financial Markets Shareholding Disclosure Chelverton Asset Management Tyman PLC
BRIEF published on 05/02/2024 at 12:59, 1 year 10 months ago Apex Fundrock Limited divulgue une position substantielle dans Tyman PLC Marchés Financiers Apex Fundrock Limitée Gestion D'actifs Chelverton Déclaration D'actionnariat Tyman PLC
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Planet 13 Holdings Schedules Q1 2024 Financial Results Release and Conference Call Financial Results Conference Call Cannabis Industry Planet 13 Holdings Q1 2024
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Planet 13 Holdings prévoit la publication des résultats financiers du premier trimestre 2024 et une conférence téléphonique Résultats Financiers Conférence Téléphonique Industrie Du Cannabis Planète 13 Avoirs T1 2024
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
BRIEF published on 05/02/2024 at 12:35, 1 year 10 months ago Moderna publie ses résultats financiers et ses progrès stratégiques pour le premier trimestre 2024 Résultats Financiers Technologie ARNm Développement De Vaccins Moderne Vaccin Contre Le VRS
Published on 03/20/2026 at 13:30, 1 day 8 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 9 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 23 hours 24 minutes ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 1 hour ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 1 hour ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 1 hour ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 2 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 3 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 3 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 3 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 3 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
